AlphaMadera's AlphaVal page computes Agilent Technologies, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag A as undervalued, fairly valued, or overvalued.

What is Agilent Technologies, Inc.'s fair value?

Fair value for A is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value A?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from A's most recent reported fundamentals.

A - Agilent Technologies, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $163.33 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 16.7% above fair value

Current Price $114.96

Bear Case $78.80 31.5% downside ($78.80 - $114.96) / $114.96 = -31.5% $4.71 × 12x P/E

Fair Value $98.48 14.3% downside ($98.48 - $114.96) / $114.96 = -14.3% $4.71 × 15x P/E

Bull Case $118.18 2.8% upside ($118.18 - $114.96) / $114.96 = 2.8% $4.71 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

4.71$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 24.4x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $163.33 from 38 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $98.48 per share.

Warnings

ℹ Dividend-based valuation: $27.90 (below our primary estimate by 61%). Large gaps may signal the dividend doesn't reflect full earning power.

ℹ Wall Street's average price target is $163.33 (from 38 analysts). Our estimate is 57% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples